Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TrivarX Limited ( (AU:TRI) ) has shared an update.
TrivarX Limited reported a collapse in revenue from ordinary activities to $2,270 for the half-year ended 31 December 2025, compared with $1.13 million a year earlier, while its net loss attributable to members widened sharply to $1.26 million from $91,083. The company did not declare an interim dividend, though net tangible assets per share rose to 0.248 cents, and its auditor highlighted a material uncertainty over TrivarX’s ability to continue as a going concern, underscoring ongoing financial pressure despite the accounts being prepared on a going concern basis.
The board confirmed no dividends were paid or recommended for the period, and there were no changes in control, associates, or joint ventures, suggesting a relatively static corporate structure. The auditor’s emphasis of matter, while not a qualification, signals heightened risk for stakeholders as the company navigates sustained losses and relies on its existing capital base to support operations.
The most recent analyst rating on (AU:TRI) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on TrivarX Limited stock, see the AU:TRI Stock Forecast page.
More about TrivarX Limited
TrivarX Limited is an Australia-based company listed on the ASX, reporting in Australian dollars. The firm appears to be in a developmental or early-stage commercial phase, as indicated by minimal revenues, recurring losses, and the absence of dividend payments to shareholders.
YTD Price Performance: 15.79%
Average Trading Volume: 1,461,521
Technical Sentiment Signal: Hold
Current Market Cap: A$26.53M
For an in-depth examination of TRI stock, go to TipRanks’ Overview page.

